514 related articles for article (PubMed ID: 32034646)
1. The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity.
Timm KN; Tyler DJ
Cardiovasc Drugs Ther; 2020 Apr; 34(2):255-269. PubMed ID: 32034646
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity.
He L; Liu F; Li J
Cardiovasc Toxicol; 2021 Mar; 21(3):179-191. PubMed ID: 33438065
[TBL] [Abstract][Full Text] [Related]
4. Apelin-13 Reverses Bupivacaine-Induced Cardiotoxicity via the Adenosine Monophosphate-Activated Protein Kinase Pathway.
Ye Y; Cai Y; Xia E; Shi K; Jin Z; Chen H; Xia F; Xia Y; Papadimos TJ; Xu X; Liu L; Wang Q
Anesth Analg; 2021 Oct; 133(4):1048-1059. PubMed ID: 34524989
[TBL] [Abstract][Full Text] [Related]
5. AICAR confers prophylactic cardioprotection in doxorubicin-induced heart failure in rats.
Choksey A; Carter RD; Thackray BD; Ball V; Kennedy BWC; Ha LHT; Sharma E; Broxholme J; Castro-Guarda M; Murphy MP; Heather LC; Tyler DJ; Timm KN
J Mol Cell Cardiol; 2024 Jun; 191():12-22. PubMed ID: 38643934
[TBL] [Abstract][Full Text] [Related]
6. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis.
Liu D; Ma Z; Di S; Yang Y; Yang J; Xu L; Reiter RJ; Qiao S; Yuan J
Free Radic Biol Med; 2018 Dec; 129():59-72. PubMed ID: 30172748
[TBL] [Abstract][Full Text] [Related]
7. AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease.
Wong AK; Howie J; Petrie JR; Lang CC
Clin Sci (Lond); 2009 Apr; 116(8):607-20. PubMed ID: 19275766
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of AMP-activated protein kinase α (AMPKα) by doxorubicin accentuates genotoxic stress and cell death in mouse embryonic fibroblasts and cardiomyocytes: role of p53 and SIRT1.
Wang S; Song P; Zou MH
J Biol Chem; 2012 Mar; 287(11):8001-12. PubMed ID: 22267730
[TBL] [Abstract][Full Text] [Related]
10. Carnitine Supplementation Attenuates Sunitinib-Induced Inhibition of AMP-Activated Protein Kinase Downstream Signals in Cardiac Tissues.
Sayed-Ahmed MM; Alrufaiq BI; Alrikabi A; Abdullah ML; Hafez MM; Al-Shabanah OA
Cardiovasc Toxicol; 2019 Aug; 19(4):344-356. PubMed ID: 30644033
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective roles of sestrin 1 and sestrin 2 against doxorubicin cardiotoxicity.
Li R; Huang Y; Semple I; Kim M; Zhang Z; Lee JH
Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H39-H48. PubMed ID: 31026186
[TBL] [Abstract][Full Text] [Related]
12. AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC.
Sajan MP; Bandyopadhyay G; Miura A; Standaert ML; Nimal S; Longnus SL; Van Obberghen E; Hainault I; Foufelle F; Kahn R; Braun U; Leitges M; Farese RV
Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E179-92. PubMed ID: 19887597
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial ROS-induced ERK1/2 activation and HSF2-mediated AT
Huang CY; Chen JY; Kuo CH; Pai PY; Ho TJ; Chen TS; Tsai FJ; Padma VV; Kuo WW; Huang CY
J Cell Physiol; 2018 Jan; 233(1):463-475. PubMed ID: 28295305
[TBL] [Abstract][Full Text] [Related]
14. AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.
Tsogbadrakh B; Ryu H; Ju KD; Lee J; Yun S; Yu KS; Kim HJ; Ahn C; Oh KH
Biochem Biophys Res Commun; 2019 Feb; 509(3):680-686. PubMed ID: 30616891
[TBL] [Abstract][Full Text] [Related]
15. The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy.
Zilinyi R; Czompa A; Czegledi A; Gajtko A; Pituk D; Lekli I; Tosaki A
Molecules; 2018 May; 23(5):. PubMed ID: 29762537
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cervical cancer cell growth through activation of upstream kinases of AMP-activated protein kinase.
Yu SY; Chan DW; Liu VW; Ngan HY
Tumour Biol; 2009; 30(2):80-5. PubMed ID: 19407487
[TBL] [Abstract][Full Text] [Related]
17. The beneficial effects of AMP kinase activation against oxidative stress are associated with prevention of PPARα-cyclophilin D interaction in cardiomyocytes.
Barreto-Torres G; Hernandez JS; Jang S; Rodríguez-Muñoz AR; Torres-Ramos CA; Basnakian AG; Javadov S
Am J Physiol Heart Circ Physiol; 2015 Apr; 308(7):H749-58. PubMed ID: 25617357
[TBL] [Abstract][Full Text] [Related]
18. Microarray expression analysis in delayed cardioprotection: the effect of exercise, AICAR, or metformin and the possible role of AMP-activated protein kinase (AMPK).
Solskov L; Magnusson NE; Kristiansen SB; Jessen N; Nielsen TT; Schmitz O; Bøtker HE; Lund S
Mol Cell Biochem; 2012 Jan; 360(1-2):353-62. PubMed ID: 21964537
[TBL] [Abstract][Full Text] [Related]
19. Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission.
Liang X; Wang S; Wang L; Ceylan AF; Ren J; Zhang Y
Pharmacol Res; 2020 Jul; 157():104846. PubMed ID: 32339784
[TBL] [Abstract][Full Text] [Related]
20. A review on the cardioprotective mechanisms of metformin against doxorubicin.
Ajzashokouhi AH; Bostan HB; Jomezadeh V; Hayes AW; Karimi G
Hum Exp Toxicol; 2020 Mar; 39(3):237-248. PubMed ID: 31735071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
